Paramyxovirus accessory proteins as interferon antagonists.
about
Respiratory syncytial virus (RSV) infects neuronal cells and processes that innervate the lung by a process involving RSV G protein.Pathogen evolution and disease emergence in carnivoresParainfluenza virusesThe non-structural NS1 protein unique to respiratory syncytial virus: a two-state folding monomer in quasi-equilibrium with a stable spherical oligomerInteraction of mumps virus V protein variants with STAT1-STAT2 heterodimer: experimental and theoretical studies.Inhibition of human parainfluenza virus type 3 infection by novel small moleculesMumps virus V protein antagonizes interferon without the complete degradation of STAT1.Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsivenessHost specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products.Animal pneumoviruses: molecular genetics and pathogenesis.Association of mumps virus V protein with RACK1 results in dissociation of STAT-1 from the alpha interferon receptor complex.C-terminal region of STAT-1alpha is not necessary for its ubiquitination and degradation caused by mumps virus V proteinDeterminants of the host range restriction of replication of bovine parainfluenza virus type 3 in rhesus monkeys are polygenic.Paramyxovirus strategies for evading the interferon response.The quest for an efficacious antiviral for respiratory syncytial virus.Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice.Edmonston measles virus prevents increased cell surface expression of peptide-loaded major histocompatibility complex class II proteins in human peripheral monocytes.Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency.Nonstructural Nipah virus C protein regulates both the early host proinflammatory response and viral virulence.Prospects of RNA interference therapy in respiratory viral diseases: update 2006.Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA.Inhibition of G1P3 expression found in the differential display study on respiratory syncytial virus infection.Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses.Protein kinase PKR mediates the apoptosis induction and growth restriction phenotypes of C protein-deficient measles virus.Human metapneumovirus establishes persistent infection in the lungs of mice and is reactivated by glucocorticoid treatment.The host response and molecular pathogenesis associated with respiratory syncytial virus infection.Engineering oncolytic measles virus to circumvent the intracellular innate immune response.Measles virus for cancer therapy.Inhibition of the type I interferon antiviral response during arenavirus infection.Paramyxovirus evasion of innate immunity: Diverse strategies for common targets.The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signalingNewcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist.Overexpression of Newcastle disease virus (NDV) V protein enhances NDV production kinetics in chicken embryo fibroblasts.Respiratory syncytial virus (RSV) attachment and nonstructural proteins modify the type I interferon response associated with suppressor of cytokine signaling (SOCS) proteins and IFN-stimulated gene-15 (ISG15).Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction.Human metapneumovirus inhibits IFN-alpha signaling through inhibition of STAT1 phosphorylation.Avian metapneumovirus infection of chicken and turkey tracheal organ cultures: comparison of virus-host interactions.A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction.Evidence for phosphorylation of human parainfluenza virus type 3 C protein: mutant C proteins exhibit variable inhibitory activities in vitro.
P2860
Q24535536-7FC80F8B-E737-4DC0-9250-BBB2FB30838CQ24654956-C903E0A9-283F-4E5D-A3C4-02C2DFF76CF6Q24682952-045FD356-ABF1-41FC-A7E6-D066657CCEC2Q28533165-65FD541D-5A23-49C7-8640-D9380BD989ACQ30394753-5A4CE496-36AD-46C0-9B9C-FF76743F0E78Q33304137-0F24DCB6-F6EF-4EB6-8D0E-E3072D0C0CDEQ33707477-25C05DF1-B963-43D8-9EF8-39D81B6F4964Q33883942-9AD2046F-3FAB-48D8-B5A4-F5DB4A18B58BQ33920551-D1C62D62-FE04-46FF-A3B9-AEEBE605F37DQ34313560-78679E61-BE29-43B0-9E59-865B0C9BD31DQ34351347-A19CB258-BCF4-4074-98E2-E1E4C6C5784CQ34351828-AD727954-CA85-43D9-B34E-5651FDF63636Q34465213-4897AC29-A632-4D9B-BA56-F4A51964F8CAQ34985852-2ED67567-35FD-4C92-9097-D73BCCB12D41Q35115949-332F7805-48BE-487E-8845-DD60ED8B53CFQ35222083-F87584DF-92A8-4B2F-8C5E-8AE68641918EQ35785013-53D04505-BDFE-4BF9-8F18-94652FB6AFAAQ35803108-3BCC4673-B3AB-4293-826C-48615D814EACQ35861936-320EBEF5-2FE7-41E0-BDCF-231EA59E3B82Q36276572-B89329D1-B5C8-4F8B-8500-8647209456F8Q36627248-763E4255-0D73-458D-B2FF-4C61ABB3B60DQ36933945-7B1B92A6-478E-459C-8E79-612F728AAFF1Q36948124-58E487F6-8FBB-4852-8E91-F99179C12C5AQ36961947-21641DED-EFCB-430C-A26C-0807D32141E4Q37033277-9FB0A7B5-C61C-479F-A47F-BE4670B831EEQ37232888-DBE70E92-AA6D-491A-9569-24EC99DA1B02Q37263779-1F6F9DAF-E402-4F4E-94B0-BC9DC36611EFQ37324179-D4F4F83D-E2F2-4754-A88A-19981A7037CCQ37388577-44FCBCDD-DE83-4627-A9A0-FBE61F33375DQ37945195-00EBE929-14E8-4A4E-A2FC-B85C1384D54FQ38156883-2F7230E5-BB63-4ABA-B7C7-9BAD7EB38A33Q39732576-D214EFD6-5EC6-4EFA-BD6B-7613EC1A73E3Q39796662-0105DCED-9A68-4C61-ABCE-2F379C15BAA1Q39803651-54758405-155B-4BBA-A09A-8933FDD8C928Q39929993-6E0A45D0-FFCB-4DED-AFB6-FE44A3A4128FQ39963611-7F70D6E2-F331-496C-88BB-B995E86C9712Q40020797-578695B6-1C28-496F-B271-FB83538ADD1BQ41002770-A01C0EDF-E625-458E-8202-46E5567F3099Q41898857-65637398-3D54-4EBF-B808-B2C9704E2D9DQ42046987-66F1A9E7-4D63-4475-A3E6-95714B232436
P2860
Paramyxovirus accessory proteins as interferon antagonists.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Paramyxovirus accessory proteins as interferon antagonists.
@ast
Paramyxovirus accessory proteins as interferon antagonists.
@en
Paramyxovirus accessory proteins as interferon antagonists.
@nl
type
label
Paramyxovirus accessory proteins as interferon antagonists.
@ast
Paramyxovirus accessory proteins as interferon antagonists.
@en
Paramyxovirus accessory proteins as interferon antagonists.
@nl
prefLabel
Paramyxovirus accessory proteins as interferon antagonists.
@ast
Paramyxovirus accessory proteins as interferon antagonists.
@en
Paramyxovirus accessory proteins as interferon antagonists.
@nl
P2093
P2860
P1476
Paramyxovirus accessory proteins as interferon antagonists.
@en
P2093
P2860
P304
P356
10.1111/J.1348-0421.2001.TB01315.X
P577
2001-01-01T00:00:00Z